TORONTO, Nov. 15 /CNW/ - Mr. Herbert Abramson, a Director of Lorus
Therapeutics Inc. ("Lorus"), announces that he has acquired directly or
indirectly, 4,257,525 common shares of Lorus (including common stock options
exercisable into 50,000 common shares), representing 2.0% of the issued and
outstanding common shares.
Abramson now owns directly or indirectly 25,946,625 common shares and
common stock options exercisable into 50,000 common shares. Assuming the
exercise of these options, Abramson would own 25,996,625 common shares,
representing approximately 12.2% of the then issued and outstanding common
Mr. Abramson has acquired the securities of Lorus for investment
purposes. Mr. Abramson reserves the right to acquire further securities of
Lorus depending on market conditions and other relevant factors.
The common shares of Lorus trade on the Toronto Stock Exchange.
An early warning report in respect of the above noted transactions will
be filed on SEDAR. A copy of this report and further information can be
Tel: (416) 956-9334
Fax: (416) 867-9771
For further information:
For further information: Herbert Abramson, Tel: (416) 956-9334, Fax: